S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

Allogene Therapeutics (ALLO) Short Interest Ratio & Short Volume

$4.91
-0.21 (-4.10%)
(As of 04:00 PM ET)

Allogene Therapeutics Short Interest Data

Current Short Volume
23,450,000 shares
Previous Short Volume
23,090,000 shares
Change Vs. Previous Month
+1.56%
Dollar Volume Sold Short
$116.31 million
Short Interest Ratio / Days to Cover
7.7
Last Record Date
February 15, 2024
Outstanding Shares
168,280,000 shares
Float Size
103,860,000 shares
Short Percent of Float
22.58%
Today's Trading Volume
1,664,125 shares
Average Trading Volume
2,840,687 shares
Today's Volume Vs. Average
59%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Allogene Therapeutics ?

Sign up to receive the latest short interest report for Allogene Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ALLO Short Interest Over Time

ALLO Days to Cover Over Time

ALLO Percentage of Float Shorted Over Time


Allogene Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/202423,450,000 shares $116.31 million +1.6%22.6%7.7 $4.96
1/31/202423,090,000 shares $81.28 million -23.6%22.2%7.4 $3.52
1/15/202430,210,000 shares $97.28 million -3.5%28.5%10.3 $3.22
12/31/202331,320,000 shares $100.54 million -6.7%29.6%11.9 $3.21
12/15/202333,550,000 shares $90.92 million +5.3%31.7%14.3 $2.71
11/30/202331,860,000 shares $74.87 million -1.5%30.1%16.8 $2.35
11/15/202332,340,000 shares $87.96 million -5.0%30.6%18.9 $2.72
10/31/202334,030,000 shares $95.96 million +10.7%32.2%22 $2.82
10/15/202330,730,000 shares $98.03 million -10.0%29.2%18 $3.19
9/30/202334,130,000 shares $108.19 million +2.1%32.2%19 $3.17
9/15/202333,420,000 shares $130.00 million +4.1%31.5%16.2 $3.89
8/31/202332,110,000 shares $124.91 million -2.0%30.3%12.4 $3.89
8/15/202332,770,000 shares $133.70 million -13.6%30.9%12.5 $4.08
7/31/202337,910,000 shares $188.03 million -8.1%39.4%14.3 $4.96
7/15/202341,260,000 shares $204.65 million +8.1%53.9%15.3 $4.96
6/30/202338,180,000 shares $189.75 million +1.7%49.9%14.1 $4.97
6/15/202337,560,000 shares $186.67 million -6.2%49.1%15.1 $4.97
5/31/202340,030,000 shares $210.16 million -1.4%52.1%20.4 $5.25
5/15/202340,590,000 shares $273.58 million -0.2%52.8%19.6 $6.74
4/30/202340,650,000 shares $220.73 million -1.4%53.3%20.3 $5.43
4/15/202341,220,000 shares $205.69 million +0.5%54.5%22.2 $4.99
3/31/202341,010,000 shares $202.59 million +3.0%54.3%22.5 $4.94
3/15/202339,800,000 shares $225.27 million +8.0%49.6%20.9 $5.66
2/28/202336,860,000 shares $234.06 million +4.9%46.0%19.4 $6.35
2/15/202335,140,000 shares $254.06 million +2.1%44.0%18.4 $7.23
1/31/202334,410,000 shares $265.65 million +0.7%43.1%18 $7.72
1/15/202334,160,000 shares $241.17 million +2.2%42.7%18.1 $7.06
12/30/202233,430,000 shares $210.27 million +9.5%41.8%18 $6.29
12/15/202230,530,000 shares $216.15 million +0.2%38.2%16 $7.08
11/30/202230,470,000 shares $300.43 million -3.2%38.1%16.5 $9.86
11/15/202231,460,000 shares $311.45 million +1.6%39.3%18.2 $9.90
10/31/202230,960,000 shares $318.89 million +3.0%39.3%18.3 $10.30
10/15/202230,050,000 shares $305.91 million +8.9%38.3%18 $10.18
9/30/202227,590,000 shares $297.97 million +24.2%35.2%16 $10.80
9/15/202222,220,000 shares $311.08 million +0.9%28.3%12.8 $14.00
8/31/202222,020,000 shares $301.89 million -2.4%28.1%12 $13.71
8/15/202222,570,000 shares $390.01 million +0.8%28.8%11.6 $17.28
7/31/202222,400,000 shares $290.75 million -0.1%28.6%10.9 $12.98
7/15/202222,430,000 shares $287.33 million -0.3%28.6%10.2 $12.81
6/30/202222,490,000 shares $256.39 million +2.0%28.5%10.5 $11.40













ALLO Short Interest - Frequently Asked Questions

What is Allogene Therapeutics' current short interest?

Short interest is the volume of Allogene Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 15th, investors have sold 23,450,000 shares of ALLO short. 22.58% of Allogene Therapeutics' shares are currently sold short. Learn More on Allogene Therapeutics' current short interest.

What is a good short interest ratio for Allogene Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALLO shares currently have a short interest ratio of 8.0. Learn More on Allogene Therapeutics's short interest ratio.

Which institutional investors are shorting Allogene Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Allogene Therapeutics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Allogene Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.58% of Allogene Therapeutics' floating shares are currently sold short.

Is Allogene Therapeutics' short interest increasing or decreasing?

Allogene Therapeutics saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 23,450,000 shares, an increase of 1.6% from the previous total of 23,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Allogene Therapeutics' float size?

Allogene Therapeutics currently has issued a total of 168,280,000 shares. Some of Allogene Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Allogene Therapeutics currently has a public float of 103,860,000 shares.

How does Allogene Therapeutics' short interest compare to its competitors?

22.58% of Allogene Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Allogene Therapeutics: Exscientia plc (3.22%), REGENXBIO Inc. (10.58%), HilleVax, Inc. (3.03%), Fusion Pharmaceuticals Inc. (9.39%), Tourmaline Bio, Inc. (4.43%), Cullinan Oncology, Inc. (2.94%), Fate Therapeutics, Inc. (15.46%), CARGO Therapeutics, Inc. (6.96%), Caribou Biosciences, Inc. (12.47%), Editas Medicine, Inc. (15.42%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Allogene Therapeutics stock?

Short selling ALLO is an investing strategy that aims to generate trading profit from Allogene Therapeutics as its price is falling. ALLO shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Allogene Therapeutics?

A short squeeze for Allogene Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALLO, which in turn drives the price of the stock up even further.

How often is Allogene Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALLO, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ALLO) was last updated on 2/29/2024 by MarketBeat.com Staff